Vontobel Holding’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Vontobel Holding’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,841	Closed	-$663K	–	1174
2022 Q4	$663K	Sell	5,841 -35,036	-86%	-$2.91M	0.01%	675
2022 Q3	$2.53M	Buy	40,877 +7,987	+24%	+$558K	0.03%	363
2022 Q2	$2.71M	Buy	32,890 +19,282	+142%	+$1.83M	0.03%	345
2022 Q1	$1.44M	Sell	13,608 -1,914	-12%	-$187K	0.01%	513
2021 Q4	$1.68M	Buy	15,522 +2,130	+16%	+$232K	0.01%	488
2021 Q3	$1.47M	Buy	13,392 +2,478	+23%	+$257K	0.01%	520
2021 Q2	$1.04M	Buy	+10,914	New	+$1M	0.01%	587

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vontobel Holding's HZNP Position: Q1 2023 in Review

Vontobel Holding sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 5,841 shares — an estimated $663K sold.

Vontobel Holding first reported a position in HZNP in Q2 2021 and held it in 7 quarters. The position peaked at $2.71M in Q2 2022. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Vontobel Holding reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Vontobel Holding sold 5,841 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $663K.
Vontobel Holding first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2021 and held it in 7 quarters.
Vontobel Holding's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.71M in Q2 2022.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Vontobel Holding's 13F filing for Q1 2023, filed 12 Apr 2023.